Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Wound Infection | Case report

First case report of bacteremia caused by Solobacterium moorei in China, and literature review

Authors: Wen-Jing Liu, Meng Xiao, Jie Yi, Ying Li, Timothy Kudinha, Ying-Chun Xu

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Solobacterium moorei, the only species in the genus Solobacterium, is a Gram-positive, non-spore-forming, strict anaerobic, short to long bacillus. It has rarely been documented to cause blood stream infections. Here we report the first case of bacteremia caused by S.moorei in China.

Case presentation

A 61-year-old male presented to Peking Union Medical College Hospital (Beijing) with thrombotic thrombocytopenic purpura (TTP) and several other underlying diseases. He also had persistent coma accompanied by intermittent convulsions, halitosis, and intermittent fever. Blood cultures taken when the patient had a high fever were positive, with the anaerobic bottle yielding an organism identified as S.moorei by 16S rRNA gene sequencing, whilst the aerobic bottle grew Streptococcus mitis. After replacement of venous pipeline, and empirical use of vancomycin and meropenem, the patient’s body temperature and white blood cell count returned to normal. Unfortunately, the patient died of severe TTP.

Conclusion

This is the first case report of S. moorei isolation from blood stream in China. 16S rRNA gene sequencing is the only method that can identify S. moorei. Blood cultures must be taken before administration of antibiotics, and anaerobic culture should be considered for such rare pathogens in patients with oral diseases and immune deficiency.
Literature
1.
go back to reference Kageyama A, Benno Y. Phylogenic and phenotypic characterization of some Eubacterium-like isolates from human feces: description of Solobacterium moorei gen. Nov., Sp. Nov. Microbiol Immunol. 2000;44(4):223–7.CrossRef Kageyama A, Benno Y. Phylogenic and phenotypic characterization of some Eubacterium-like isolates from human feces: description of Solobacterium moorei gen. Nov., Sp. Nov. Microbiol Immunol. 2000;44(4):223–7.CrossRef
2.
go back to reference Downes J, Munson MA, Spratt DA, Kononen E, Tarkka E, Jousimies-Somer H, Wade WG. Characterisation of Eubacterium-like strains isolated from oral infections. J Med Microbiol. 2001;50(11):947–51.CrossRef Downes J, Munson MA, Spratt DA, Kononen E, Tarkka E, Jousimies-Somer H, Wade WG. Characterisation of Eubacterium-like strains isolated from oral infections. J Med Microbiol. 2001;50(11):947–51.CrossRef
3.
go back to reference Haraszthy VI, Zambon JJ, Sreenivasan PK, Zambon MM, Gerber D, Rego R, Parker C. Identification of oral bacterial species associated with halitosis. J Am Dent Assoc. 2007;138(8):1113–20.CrossRef Haraszthy VI, Zambon JJ, Sreenivasan PK, Zambon MM, Gerber D, Rego R, Parker C. Identification of oral bacterial species associated with halitosis. J Am Dent Assoc. 2007;138(8):1113–20.CrossRef
4.
go back to reference Haraszthy VI, Gerber D, Clark B, Moses P, Parker C, Sreenivasan PK, Zambon JJ. Characterization and prevalence of Solobacterium moorei associated with oral halitosis. J Breath Res. 2008;2(1):017002.CrossRef Haraszthy VI, Gerber D, Clark B, Moses P, Parker C, Sreenivasan PK, Zambon JJ. Characterization and prevalence of Solobacterium moorei associated with oral halitosis. J Breath Res. 2008;2(1):017002.CrossRef
5.
go back to reference Kazor CE, Mitchell PM, Lee AM, Stokes LN, Loesche WJ, Dewhirst FE, Paster BJ. Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients. J Clin Microbiol. 2003;41(2):558–63.CrossRef Kazor CE, Mitchell PM, Lee AM, Stokes LN, Loesche WJ, Dewhirst FE, Paster BJ. Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients. J Clin Microbiol. 2003;41(2):558–63.CrossRef
6.
go back to reference Rocas IN, Hulsmann M, Siqueira JF Jr. Microorganisms in root canal-treated teeth from a German population. J Endod. 2008;34(8):926–31.CrossRef Rocas IN, Hulsmann M, Siqueira JF Jr. Microorganisms in root canal-treated teeth from a German population. J Endod. 2008;34(8):926–31.CrossRef
7.
go back to reference Rolph HJ, Lennon A, Riggio MP, Saunders WP, MacKenzie D, Coldero L, Bagg J. Molecular identification of microorganisms from endodontic infections. J Clin Microbiol. 2001;39(9):3282–9.CrossRef Rolph HJ, Lennon A, Riggio MP, Saunders WP, MacKenzie D, Coldero L, Bagg J. Molecular identification of microorganisms from endodontic infections. J Clin Microbiol. 2001;39(9):3282–9.CrossRef
8.
go back to reference Schirrmeister JF, Liebenow AL, Pelz K, Wittmer A, Serr A, Hellwig E, Al-Ahmad A. New bacterial compositions in root-filled teeth with periradicular lesions. J Endod. 2009;35(2):169–74.CrossRef Schirrmeister JF, Liebenow AL, Pelz K, Wittmer A, Serr A, Hellwig E, Al-Ahmad A. New bacterial compositions in root-filled teeth with periradicular lesions. J Endod. 2009;35(2):169–74.CrossRef
9.
go back to reference APV Colombo BSK, Cotton SL, Goodson JM, Kent R, Haffajee AD, Socransky SS, Hasturk H, Van Dyke TE, Dewhirst F, et al. Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human Oral microbe identification microarray. J Periodontol. 2009;80(9):1421–32.CrossRef APV Colombo BSK, Cotton SL, Goodson JM, Kent R, Haffajee AD, Socransky SS, Hasturk H, Van Dyke TE, Dewhirst F, et al. Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human Oral microbe identification microarray. J Periodontol. 2009;80(9):1421–32.CrossRef
10.
go back to reference Zheng G, Summanen PH, Talan D, Bennion R, Rowlinson MC, Finegold SM. Phenotypic and molecular characterization of Solobacterium moorei isolates from patients with wound infection. J Clin Microbiol. 2010;48(3):873–6.CrossRef Zheng G, Summanen PH, Talan D, Bennion R, Rowlinson MC, Finegold SM. Phenotypic and molecular characterization of Solobacterium moorei isolates from patients with wound infection. J Clin Microbiol. 2010;48(3):873–6.CrossRef
11.
go back to reference Detry G, Pierard D, Vandoorslaer K, Wauters G, Avesani V, Glupczynski Y. Septicemia due to Solobacterium moorei in a patient with multiple myeloma. Anaerobe. 2006;12(3):160–2.CrossRef Detry G, Pierard D, Vandoorslaer K, Wauters G, Avesani V, Glupczynski Y. Septicemia due to Solobacterium moorei in a patient with multiple myeloma. Anaerobe. 2006;12(3):160–2.CrossRef
12.
go back to reference Lau SK, Teng JL, Leung KW, Li NK, Ng KH, Chau KY, Que TL, Woo PC, Yuen KY. Bacteremia caused by Solobacterium moorei in a patient with acute proctitis and carcinoma of the cervix. J Clin Microbiol. 2006;44(8):3031–4.CrossRef Lau SK, Teng JL, Leung KW, Li NK, Ng KH, Chau KY, Que TL, Woo PC, Yuen KY. Bacteremia caused by Solobacterium moorei in a patient with acute proctitis and carcinoma of the cervix. J Clin Microbiol. 2006;44(8):3031–4.CrossRef
13.
go back to reference CA Martin WRS, Borland CD, Karas JA. Femoral vein thrombophlebitis and septic pulmonary embolism due to a mixed anaerobic infection including Solobacterium moorei: a case report. J Med Case Rep. 2007;1:40.CrossRef CA Martin WRS, Borland CD, Karas JA. Femoral vein thrombophlebitis and septic pulmonary embolism due to a mixed anaerobic infection including Solobacterium moorei: a case report. J Med Case Rep. 2007;1:40.CrossRef
14.
go back to reference Pedersen RM, Holt HM, Justesen US. Solobacterium moorei bacteremia: identification, antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol. 2011;49(7):2766–8.CrossRef Pedersen RM, Holt HM, Justesen US. Solobacterium moorei bacteremia: identification, antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol. 2011;49(7):2766–8.CrossRef
15.
go back to reference Blairon L, Maza ML, Wybo I, Pierard D, Dediste A, Vandenberg O. Vitek 2 ANC card versus BBL crystal anaerobe and RapID ANA II for identification of clinical anaerobic bacteria. Anaerobe. 2010;16(4):355–61.CrossRef Blairon L, Maza ML, Wybo I, Pierard D, Dediste A, Vandenberg O. Vitek 2 ANC card versus BBL crystal anaerobe and RapID ANA II for identification of clinical anaerobic bacteria. Anaerobe. 2010;16(4):355–61.CrossRef
16.
go back to reference Hall BG. Building phylogenetic trees from molecular data with MEGA. Mol Biol Evol. 2013;30(5):1229–35.CrossRef Hall BG. Building phylogenetic trees from molecular data with MEGA. Mol Biol Evol. 2013;30(5):1229–35.CrossRef
17.
go back to reference Hiranmayi KV, Sirisha K, Ramoji Rao MV, Sudhakar P. Novel pathogens in periodontal microbiology. J Pharm Bioallied Sci. 2017;9(3):155–63.CrossRef Hiranmayi KV, Sirisha K, Ramoji Rao MV, Sudhakar P. Novel pathogens in periodontal microbiology. J Pharm Bioallied Sci. 2017;9(3):155–63.CrossRef
Metadata
Title
First case report of bacteremia caused by Solobacterium moorei in China, and literature review
Authors
Wen-Jing Liu
Meng Xiao
Jie Yi
Ying Li
Timothy Kudinha
Ying-Chun Xu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4359-7

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine